- World rank, 2022–2025
- #18,948 of 28,054 · #30,926 all time
- Rank in China
- #2,786 of 3,058
- Research works
- 271 ▼ 16% vs 2013–17
- Citations
- 2.2k 8.1 per fractional work
- Top-10% rate
- 14.3% record average 16.5%
- Open access
- 31% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.6×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 12.6×
- Chemistry 3.6×
- Immunology and Microbiology 3.3×
- Chemical Engineering 2.9×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Engineering 1.6×
- Medicine 1.4×
- Materials Science 1.3×
- Neuroscience 0.9×
- Agricultural and Biological Sciences 0.8×
- Nursing 0.7×
- Environmental Science 0.6×
- Veterinary 0.5×
- Mathematics 0.5×
- Arts and Humanities 0.4×
- Dentistry 0.4×
- Economics, Econometrics and Finance 0.3×
- Energy 0.3×
- Computer Science 0.3×
- Earth and Planetary Sciences 0.3×
- Health Professions 0.2×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
Which keywords describe research at Shijiazhuang Yiling Pharmaceutical (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Herbal Medicine, Traditional Chinese Medicine, Pharmacological Effects, Phytochemistry, Antioxidant and Immunotherapy.
- Natural Products
- Glycosylation
- Medicinal Chemistry
- Glycyrrhizin
- Quality Control
- Chemical Analysis
- Neuroprotective Effects
- Anticancer
- Bioactive Compounds
- Chimeric Antigen Receptor
- Antiviral
- Leukemia
- Tumor Regression
- Lymphoma
- Cancer Immunotherapy
- Metabolism
- Phytochemistry
- Pharmacological Effects
- Immunotherapy
- Cancer
- Inflammation
- Antioxidant
- Herbal Medicine
- Traditional Chinese Medicine
- Pharmacokinetics
- Nanoparticles
- Cardiovascular Disease
- Pharmacology
- Antioxidant Activity
- Anti-inflammatory
- CAR T Cells
- Cancer Therapy
- Monoclonal Antibodies
- Biomarkers
- Biological Activities
- Hepatoprotective
- Synthesis
- Licorice
- Angiogenesis
- Therapeutic Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation6▲ 3.1×32 topics
- Cancer5▲ 4.4×26 topics
- Antioxidant4▲ 5.5×11 topics
- Immunotherapy3▲ 5.2×10 topics
- Herbal Medicine3▲ 13×3 topics
- Pharmacological Effects3▲ 55×6 topics
- Traditional Chinese Medicine3▲ 28×4 topics
- Phytochemistry3▲ 27×5 topics
- Pharmacokinetics3▲ 12×8 topics
- Metabolism3▲ 5.9×13 topics
- Nanoparticles3▲ 2.4×12 topics
- Cancer Immunotherapy3▲ 19×3 topics
- Cardiovascular Disease3▲ 2.5×8 topics
- Lymphoma3▲ 18×3 topics
- Pharmacology3▲ 11×7 topics
- Tumor Regression2▲ 24×2 topics
- Antioxidant Activity2▲ 4.1×10 topics
- Leukemia2▲ 31×2 topics
- Anti-inflammatory2▲ 9.1×12 topics
- Antiviral2▲ 31×3 topics
- CAR T Cells2▲ 35×1 topic
- Chimeric Antigen Receptor2▲ 35×1 topic
- Cancer Therapy2▲ 4.0×12 topics
- Bioactive Compounds2▲ 8.5×4 topics
- Monoclonal Antibodies2▲ 24×3 topics
- Anticancer2▲ 13×9 topics
- Biomarkers2▲ 2.9×9 topics
- Neuroprotective Effects2▲ 12×5 topics
- Biological Activities2▲ 11×5 topics
- Chemical Analysis2▲ 32×1 topic
- Hepatoprotective2▲ 22×2 topics
- Quality Control2▲ 9.4×1 topic
- Synthesis2▲ 5.0×9 topics
- Glycyrrhizin2▲ 45×1 topic
- Licorice2▲ 45×1 topic
- Medicinal Chemistry2▲ 6.1×6 topics
- Angiogenesis2▲ 5.1×6 topics
- Glycosylation1▲ 13×3 topics
- Therapeutic Antibodies1▲ 20×2 topics
- Natural Products1▲ 8.7×5 topics
Which research topics does Shijiazhuang Yiling Pharmaceutical (China) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Traditional Chinese Medicine Analysis, Pharmacological Effects of Natural Compounds and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 Traditional Chinese Medicine Analysis Complementary and alternative medicine 2 works
- 3 Pharmacological Effects of Natural Compounds Pharmacology 2 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 EFL/ESL Teaching and Learning Language and Linguistics 1 works
- 6 Plant-based Medicinal Research Pharmacology 1 works
- 7 Biosimilars and Bioanalytical Methods Immunology 1 works
- 8 Concrete and Cement Materials Research Civil and Structural Engineering 1 works
- 9 Microbial Natural Products and Biosynthesis Pharmacology 1 works
- 10 Cell Adhesion Molecules Research Immunology and Allergy 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shijiazhuang Yiling Pharmaceutical (China)'s research output changed?
Output in 2018–2022 was 16% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shijiazhuang
- Hebei Medical University
- Hebei Normal University
- Hebei University of Science and Technology
- Shijiazhuang Tiedao University
- Ordnance Engineering College
- Shijiazhuang University
- Second Hospital of Hebei Medical University
- Hebei GEO University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.